French nuclear energy company Framatome and Belgian particle accelerator technology company Ion Beam Applications (IBA) have signed a memorandum of understanding to advance the industrial-scale production of the alpha-emitting medical radioisotope astatine-211 across Europe and the United States.

Here is a recap of industry happenings over the course of the past month:

ADVANCED REACTORS MARKETPLACE

Terrestrial Energy and Cameco examine partnership for deploying IMSR Generation IV nuclear power plants

• Terrestrial Energy and Cameco Corporation have signed a non-binding and non-exclusive memorandum of understanding to examine potential partnership opportunities to deploy Terrestrial Energy’s Integrated Molten Salt Reactor (IMSR) Generation IV nuclear power plants in North America and worldwide. The partnership would also evaluate possible opportunities for the supply of uranium, fuel, and other services. As part of these activities, the companies are investigating the potential of Cameco’s Port Hope uranium conversion facility in Ontario, Canada, for IMSR fuel salt supply.